热门出版物 - 学术资源搜索

h5 指数:55
h5 中位数:78

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#17 Gastroenterology & Hepatology

标题/作者	引用次数	年份
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The Lancet Gastroenterology & Hepatology 2 (3), 161-176	912	2017
Obeticholic acid for primary biliary cholangitis H Baker LANCET GASTROENTEROLOGY & HEPATOLOGY 1 (2), 93-93	491	2016
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The Lancet Gastroenterology & Hepatology 3 (6), 383-403	296	2018
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial M Buti, E Gane, WK Seto, HLY Chan, WL Chuang, T Stepanova, AJ Hui, ... The Lancet Gastroenterology & Hepatology 1 (3), 196-206	189	2016
FGFR-altered cholangiocarcinoma H Baker LANCET GASTROENTEROLOGY & HEPATOLOGY 3 (2), 81-81	174	2018
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial HLY Chan, S Fung, WK Seto, WL Chuang, CY Chen, HJ Kim, AJ Hui, ... The Lancet Gastroenterology & Hepatology 1 (3), 185-195	173	2016
Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies AY Xiao, MLY Tan, LM Wu, VM Asrani, JA Windsor, D Yadav, MS Petrov The Lancet Gastroenterology & Hepatology 1 (1), 45-55	157	2016
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial PH Johnsen, F Hilpüsch, JP Cavanagh, IS Leikanger, C Kolstad, PC Valle, ... The Lancet Gastroenterology & Hepatology 3 (1), 17-24	150	2018
The mesentery: structure, function, and role in disease JC Coffey, DP O'Leary The Lancet Gastroenterology & Hepatology 1 (3), 238-247	146	2016
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis F Dossa, TR Chesney, SA Acuna, NN Baxter The Lancet Gastroenterology & Hepatology 2 (7), 501-513	143	2017
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ... The Lancet Gastroenterology & Hepatology 2 (5), 325-336	138	2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial T Meyer, R Fox, YT Ma, PJ Ross, MW James, R Sturgess, C Stubbs, ... The Lancet Gastroenterology & Hepatology 2 (8), 565-575	135	2017
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The Lancet Gastroenterology & Hepatology 3 (3), 153-161	130	2018
The microbiota–gut–brain axis in obesity C Torres-Fuentes, H Schellekens, TG Dinan, JF Cryan The Lancet Gastroenterology & Hepatology 2 (10), 747-756	129	2017
Pathophysiology of irritable bowel syndrome GJ Holtmann, AC Ford, NJ Talley The Lancet Gastroenterology & Hepatology 1 (2), 133-146	127	2016
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ... The Lancet Gastroenterology & Hepatology 1 (3), 207-216	116	2016
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer PA Hart, MD Bellin, DK Andersen, D Bradley, Z Cruz-Monserrate, ... The Lancet Gastroenterology & Hepatology 1 (3), 226-237	102	2016
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study J Grebely, FMJ Lamoury, B Hajarizadeh, Y Mowat, AD Marshall, S Bajis, ... The Lancet Gastroenterology & Hepatology 2 (7), 514-520	99	2017
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The Lancet Gastroenterology & Hepatology 4 (2), 135-184	94	2019
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial JG Williams, MF Alam, L Alrubaiy, I Arnott, C Clement, D Cohen, ... The Lancet Gastroenterology & Hepatology 1 (1), 15-24	92	2016

1 - 20

计算机程序会自动估算并确定日期和引用次数。